The KEMRI-Wellcome Trust Research Programme is internationally renowned for its work in tackling malaria and other infectious diseases. The programme has a strong record of conducting high-quality clinical trials to find new treatments and vaccines that are urgently needed to meet some of the major health challenges in developing countries.
To address the need for high-quality trials, the programme established a dedicated Clinical Trials Facility (CTF) to oversee the design, strategy, coordination and governance of high-quality phase I, II, III and IV clinical trials across East Africa. The facility and its processes have been designed to maximise opportunities for learning and training with the aim of developing a cadre of highly skilled and experienced African trialists from all disciplines.
We are looking for a new Head of the Clinical Trials Facility who will ensure that the facility’s strategy enables the programme to fulfil its potential as a leader in supporting world-class clinical trials in Africa. The postholder will lead on leveraging external funding sources to support the further development of the activities at the facility and will have overall responsibility for budget management (the current three-year budget is approximately $7.8 million with a portfolio of 6-8 grants). The successful candidate will have management responsibility for around 100 staff in the facility and will be responsible for capacity building activities and professional development within the facility’s operations. The postholder will also participate in the key management groups at the programme as well as advise the Scientific Director on strategic issues related to clinical trials.
To excel in this position, you will have a PhD or equivalent in a field related to health research and have significant experience in the conduct of clinical trials. Strong diplomatic skills and proven oral and written presentation skills are essential. Experience of conducting clinical trials in Africa is desirable. The post is available for three years in the first instance.
Applicants for this vacancy are to be made online. To apply for this role and for further details, including a job description and person specification, please click on the link below:
Only applications received before 12.00 midday on Friday 20 May 2011 will be considered.
Bookmarked by Trudie Lang on 3 May 2011
The President’s Emergency Plan for AIDS Relief (PEPFAR) is a global health initiative launched in 2003 with the goal of comprehensively combating the devastation due to HIV/AIDS around the world. Implementation science is the study of methods to improve the uptake, implementation, and translation of research findings into routine and common practices (the "know-do" or "evidence to program" gap). The scope of implementation science is broader than typical biomedical research; it seeks to improve program effectiveness and optimize efficiency, including the effective transfer of interventions from one setting to another. The methods of implementation science facilitate making evidence-based choices between competing or combined interventions and improving the delivery of effective and cost-effective programs. A rigorous implementation science research agenda is needed to improve program delivery in PEPFAR and to increase the global impact of proven HIV/AIDS modalities in prevention, treatment, and care. While scientific knowledge to prevent and treat HIV/AIDS has expanded substantially, scientific advances regarding the implementation of effective interventions have not kept pace. There is an unmet need for implementation science research to inform approaches and investments for public health programming and policy making. For example, research is needed to improve the dissemination and uptake of effective interventions, to deliver effective interventions most efficiently, to improve the transfer of interventions from one setting or population to another, to test the effectiveness of “at scale” combination prevention interventions, and to conduct comparative effectiveness studies to better inform choices between competing interventions. The answers to these questions should improve the operations and efficiency of a proven prevention, treatment or care intervention, and should be applicable across a broader range of targets, strategies, settings, and populations.
There is substantial expertise in the scientific community to address implementation science research questions, including questions in the fields of operations research, epidemiology, sociology, health economics, health services research, anthropology, statistics, political science, policy analysis, and ethics.
Bookmarked by The Editorial Team on 11 Apr 2011
Statistician (Worldwide Antimalarial Resistance Network)
NUFFIELD DEPARTMENT OF CLINICAL MEDICINE, Centre for Tropical Medicine
Grade 7: Salary £29,099 - £35,788 p.a.
More than 500 million become severely ill with malaria every year and more than 1 million die from the effects of the disease. The Worldwide Antimalarial Resistance Network (WWARN), working with the World Health Organisation (WHO) and funded by the Bill and Melinda Gates Foundation, will set up a global drug resistance information resource so that more of the right drugs can get to the right people at the right time, and the drugs will last longer. Details can be found on the website at http://www.wwarn.org/.
This exciting post will support the Clinical Module of WWARN, ensuring that the clinical database i) meets the requirement of the clinical team and other stakeholders, ii) works with the database architecture (designed in collaboration with the informatics team), and iii) allows cross-referencing between the Clinical, In Vitro, Molecular and Pharmacological Modules of WWARN. The successful candidate will develop a wide variety of research and analytical tools including but not limited to: clinical trial, meta-analysis and time-series analyses.
You will have a postgraduate qualification in data analysis or statistics (or equivalent work experience), and experience working with database developers. Experience of working with data from countries in Africa, Asia or Latin America is highly desirable.
Bookmarked by The Editorial Team on 7 Apr 2011
EpiSurveyor is a web- and mobile- tool to allow organizations to gather research, management, and other data from the field using common mobile phones, and winner of the 2009 Wall Street Journal Award for Technology Innovation in the category of healthcare. It is not limited to health-related data, and is attracting users from a variety of other fields.
As easy as Gmail, free to 99% of users, with 3000 users in 150+ countries worldwide. If you are collecting data using paper and clipboard, you could probably be using EpiSurveyor to do real-time mobile electronic data collection.
Bookmarked by Joel Selanikio on 14 Jan 2011
This is an advanced Immunology course held twice a year (March and September) on site at the Uganda Virus Research Institute in Entebbe, Uganda. Our courses of formal lectures from international faculty, journal clubs, revision sessions and practical classes. These courses are suitable for postgraduate students (MSc, PhD), as well as qualified doctors who have an interest in expanding their Immunological knowledge and techniques.
Our March course offers modules on the Evolution of the Immune System, Malaria Immunology and Helminth Immunology. In our September course we offer modules on Fundamental Immunology, TB Immunology and HIV Immunology. Our practical sessions give instruction on ELISA techniques, as well as ELISPOT, real time PCR design and flow cytometry.
Please visit the website for further information, or email firstname.lastname@example.org
Bookmarked by Stephen Cose on 7 Dec 2010